Granules Pharmaceuticals Inc. recalls

10 recalls on record · latest: January 26, 2026

Official U.S. recall history for Granules Pharmaceuticals Inc., compiled from official government records.

Get recall alerts

Free email alert whenever Granules Pharmaceuticals Inc. has a new recall — straight from official government data. Unsubscribe anytime.

Granules Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-co…

June 24, 2025 · Drug & medication recalls Moderate risk Failed Dissolution Specifications: Product failed to meet dissolution acceptanc…

Granules Pharmaceuticals Inc. recalls Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000-count bottles, Rx Only, Manufactured by: Granules I…

December 30, 2024 · Drug & medication recalls Moderate risk Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in…

Granules Pharmaceuticals Inc. recalls Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 201…

December 18, 2024 · Drug & medication recalls Moderate risk Failed Dissolution Specifications: Out of specification observed during the acc…

Granules Pharmaceuticals Inc. recalls Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081,…

July 31, 2024 · Drug & medication recalls Moderate risk Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found…